Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality

Abhishek Maiti, Wei Qiao, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Elias J. Jabbour, Naval G. Daver, Gautam Borthakur, Guillermo Garcia-Manero, Sherry A. Pierce, Kathryn S. Montalbano, Naveen Pemmaraju, Kiran Naqvi, Maro Ohanian, Nicholas J. Short, Yesid Alvarado, Koichi Takahashi, Musa Yilmaz, Nitin Jain, Steven M. KornblauMichael Andreeff, Prithviraj Bose, Alessandra Ferrajoli, Ghayas C. Issa, Lucia Masarova, Philip A. Thompson, Caitlin R. Rausch, Jing Ning, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Y. Konopleva

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Nursing and Health Professions